Drugs / Recombinant grass pollen
Recombinant grass pollen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00309036 | Jan 2004 → Sep 2006 | allergic disease | Allergopharma GmbH & Co. KG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant grass pollen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00309036 ↗ |
| Modality | Protein / enzyme biologic | “Cocktail of Recombinant Derivatives of Major Allergens of Timothy Grass” NCT00309036 ↗ |